146 related articles for article (PubMed ID: 6130680)
1. Rationale for combined alpha-beta-adrenoceptor blockade: haemodynamic considerations.
Koch G
Acta Med Scand Suppl; 1982; 665():87-92. PubMed ID: 6130680
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
Koch G
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
[TBL] [Abstract][Full Text] [Related]
3. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Koch G
Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
5. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
6. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
van Zwieten PA
Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
Koch G; Fransson L
Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
Koch G
Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic effects of beta-receptor blockade during acute administration and chronic treatment.
Jensen HA
Acta Med Scand Suppl; 1982; 665():79-81. PubMed ID: 6130678
[TBL] [Abstract][Full Text] [Related]
15. The hemodynamic effects of adrenergic blocking agents.
Lund-Johansen P
Cleve Clin J Med; 1992; 59(2):193-200. PubMed ID: 1350235
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
17. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
Lund-Johansen P
Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic and physiologic considerations of adrenoceptor blockade.
Frohlich ED; Dunn FG; Messerli FH
Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
[TBL] [Abstract][Full Text] [Related]
19. Alpha- and beta-blockade in angina pectoris.
Taylor SH
Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic differences in untreated hypertension and hypertension treated with various beta-adrenoceptor antagonists.
Weil C; Waite R
Br J Clin Pharmacol; 1982; 13(Suppl 2):279S-283S. PubMed ID: 6125177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
